The latest market price reference for dacomitinib/dacomitinib in 2025

Dacomitinib/Dacomitinib (Dacomitinib) is an important targeted drug in the treatment of non-small cell lung cancer (NSCLC) in recent years, especially for patients with EGFR mutations. Its original drug has been launched in China and has entered the scope of Class B medical insurance, making treatment affordable for more patients.

According to market research, the price of dacomitinib with a common domestic specification of 15mg*30 tablets is about more than 1,000 yuan. Compared with other targeted drugs, this price is relatively affordable, especially under the coverage of medical insurance, which greatly reduces the financial burden of patients. It's worth noting that prices may fluctuate depending on the region and drug supplier.

Overseas, the price of dacomitinib’s original drug (such as the European version) is relatively high. The specification is 45mg*30 tablets, and the price per box may be as high as more than 20,000 yuan (this price will fluctuate due to exchange rate changes). This is because pricing in overseas markets is usually higher and there is no medical insurance support, so patients need to bear a larger portion of the cost themselves.

In addition to the original drug, some generic drugs of dacomitinib have also appeared on the market, which are relatively cheap, especially in some parts of Asia. For example, the price of the dacomitinib generic drug produced by Lucius Pharmaceutical Factory and Element Pharmaceutical Factory in Laos is 45mg*30 tablets, which may be around 800 yuan (also affected by exchange rate fluctuations). The ingredients of these generic drugs are consistent with the original drugs, providing patients with a more economical choice.

Generally speaking, the price of dacomitinib is greatly affected by region, exchange rate and whether it is an original drug. Patients can make corresponding decisions based on their own economic situation and medical insurance policy when choosing.

Reference materials:https://www.pfizer.com/products/product-detail/vizimpro